Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Cv 3317
2. Cv-3317
3. Delapril
4. Derapril
5. N-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)alanyl)glycine
1. Delapril Hcl
2. 83435-67-0
3. Adecut
4. Rev 6000a
5. Cv 3317
6. Rev-6000a
7. 2smm3m5zmh
8. Cv-3317
9. Ethyl (s)-2-(((s)-1-((carboxymethyl)-2-indanylcarbamoyl)ethyl)amino)-4-phenylbutyrate, Monohydrochloride
10. Delapril (hydrochloride)
11. 2-[2,3-dihydro-1h-inden-2-yl-[(2s)-2-[[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]amino]acetic Acid;hydrochloride
12. Glycine, N-(2,3-dihydro-1h-inden-2-yl)-n-(n-(1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl)-, Monohydrochloride, (s)-
13. Indalapril
14. 2-((s)-n-(2,3-dihydro-1h-inden-2-yl)-2-(((s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic Acid Hydrochloride
15. 2-[(2s)-n-(2,3-dihydro-1h-inden-2-yl)-2-{[(2s)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanamido]acetic Acid Hydrochloride
16. Ccris 1925
17. Delapril Hydrochloride [usan:jan]
18. Ncgc00181755-01
19. Unii-2smm3m5zmh
20. Cupressin
21. Delaket
22. Adecut (tn)
23. Delapril?hydrochloride
24. Alindapril Hydrochloride
25. Dsstox_cid_28523
26. Dsstox_rid_82795
27. N-(n-((s)-1-ethoxycarbonyl-3-phenylpropyl)-l-alanyl)-n-(indan-2-yl)glycine Hydrochloride
28. Dsstox_gsid_48597
29. Glycine, N-((1s)-1-(ethoxycarbonyl)-3-phenylpropyl)-l-alanyl-n-(2,3-dihydro-1h-inden-2-yl)-, Monohydrochloride
30. Schembl120907
31. Chembl2106126
32. Dtxsid6048597
33. Chebi:31462
34. Delapril Hydrochloride [mi]
35. Delapril Hydrochloride (jan/usan)
36. Delapril Hydrochloride [jan]
37. Tox21_112927
38. Delapril Hydrochloride [usan]
39. Mfcd00884619
40. S5728
41. Akos015915580
42. Delapril Hydrochloride [mart.]
43. Ccg-269602
44. Delapril Hydrochloride [who-dd]
45. As-15996
46. Cas-83435-67-0
47. Hy-107337
48. Cs-0028174
49. D4082
50. D01667
51. Q27255552
52. N-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl-n-(2-indanyl)glycine Hydrochloride
53. N-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-n-(indan-2-yl)glycine Hydrochloride
54. 2-((s)-n-(2,3-dihydro-1h-inden-2-yl)-2-((s)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanamido)acetic Acid Hydrochloride
55. Glycine,n-[(1s)-1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl-n-(2,3-dihydro-1h-inden-2-yl)-, Monohydrochloride
56. N-[(s)-1-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-n-(2,3-dihydroinden-2-yl)glycine Hydrochloride
Molecular Weight | 489.0 g/mol |
---|---|
Molecular Formula | C26H33ClN2O5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 12 |
Exact Mass | 488.2077999 g/mol |
Monoisotopic Mass | 488.2077999 g/mol |
Topological Polar Surface Area | 95.9 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 649 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Angiotensin-Converting Enzyme Inhibitors
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Market Place
ABOUT THIS PAGE
A Delapril Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Delapril Hydrochloride, including repackagers and relabelers. The FDA regulates Delapril Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Delapril Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Delapril Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Delapril Hydrochloride supplier is an individual or a company that provides Delapril Hydrochloride active pharmaceutical ingredient (API) or Delapril Hydrochloride finished formulations upon request. The Delapril Hydrochloride suppliers may include Delapril Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Delapril Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Delapril Hydrochloride Drug Master File in Japan (Delapril Hydrochloride JDMF) empowers Delapril Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Delapril Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Delapril Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Delapril Hydrochloride suppliers with JDMF on PharmaCompass.
A Delapril Hydrochloride written confirmation (Delapril Hydrochloride WC) is an official document issued by a regulatory agency to a Delapril Hydrochloride manufacturer, verifying that the manufacturing facility of a Delapril Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Delapril Hydrochloride APIs or Delapril Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Delapril Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Delapril Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Delapril Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Delapril Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Delapril Hydrochloride GMP manufacturer or Delapril Hydrochloride GMP API supplier for your needs.
A Delapril Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Delapril Hydrochloride's compliance with Delapril Hydrochloride specifications and serves as a tool for batch-level quality control.
Delapril Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Delapril Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Delapril Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Delapril Hydrochloride EP), Delapril Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Delapril Hydrochloride USP).
LOOKING FOR A SUPPLIER?